Advertise on podcast: STAT Stitch Deep Dive Podcast Beyond The Bedside

Rating

★★★★★

from

1 reviews

Description

***STAT Stitch UPDATE*** https://statstitch.etsy.com click the link to buy a shirt to help and support the channel. Instead of asking for free money I am trying to provide you with some value to help me offset some of the cost it takes to run the channel. so if you like the shirt grab one or 4 and spread the word! Welcome to STAT Stitch Deep Dive: Beyond the Bedside, the podcast where nursing knowledge, clinical storytelling, and the realities of nursing school collide. Whether you’re a current nursing student, preparing for boards, or a new nurse navigating your first year at the bedside, this show is designed to give you the mix of insight, clarity, and encouragement you need to succeed in both the classroom and the hospital. Hosted by a trauma nurse and nursing student who’s living the journey alongside you, each episode combines Audio Overviews—broken down into conversational, easy-to-digest lessons—with real-world reflections and practical nursing tips. The goal? To simplify complex concepts and help connect theory to clinical practice. What You’ll Hear on the Podcast: Deep Dives into Nursing Content: From pathophysiology to pharmacology, each overview is presented in a way that feels like you’re sitting down with a mentor who explains not just the “what,” but the “why.” These episodes break down intimidating topics into clear, conversational lessons that stick. Nursing Management Focus: Every content-heavy episode goes beyond theory to explore how you’ll actually manage a patient at the bedside. If it’s pathophysiology, we’ll dive into the nursing management of those manifestations. If it’s pharmacology, we’ll cover nursing considerations, indications, and patient safety. Chronicles from Nursing School: Think of this as a mini audio diary—stories from the trenches of nursing education. From late-night study sessions and clinical rotations to exam wins (and fails), these episodes highlight the challenges, growth, and resilience that every student nurse will relate to. Practical Nursing Tips: Every episode closes with a tip you can immediately apply—whether it’s a study hack, a clinical shortcut, or a mindset strategy to stay resilient during stressful shifts. Why This Podcast? Because nursing school is hard—and the transition to practice can feel overwhelming. STAT Stitch Deep Dive bridges the gap between theory and bedside, helping you connect what you’re learning in your textbooks to the realities of patient care. You’ll get evidence-based content delivered in a friendly, conversational style that feels more like a study group than a lecture. Who Should Listen? Nursing students (ADN, BSN, accelerated, or bridge programs) Pre-nursing students preparing for the rigors ahead New graduates in their first year of practice Nurses preparing for the NCLEX or refreshing their knowledge Anyone passionate about nursing education, patient safety, and the art of caring beyond the bedside. This podcast is for anyone searching for nursing school tips, NCLEX prep, clinical practice advice, study hacks for nurses, nursing student motivation, bedside nursing skills, pathophysiology explained, pharmacology made simple, nursing management strategies, and the realities of life as a nurse. At its core, STAT Stitch Deep Dive: Beyond the Bedside is about stitching together knowledge, experience, and humanity. It’s not just about surviving nursing school—it’s about thriving as a future nurse who can think critically, act compassionately, and manage confidently at the bedside. So if you’re ready to go beyond memorization, beyond the stress, and beyond the bedside—hit play, subscribe, and join the conversation. Because in nursing, every detail matters. And here, we stitch them together.

Unlock STAT Stitch Deep Dive Podcast Beyond The Bedside podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from STAT Stitch Deep Dive Podcast Beyond The Bedside podcast

PLUG | STAT Stitch and DudeRNCreations Products 8 )

2026/02/07

https://statstitch.etsy.com STAT Stitch clothing is now here. The wait is over. We finally made shirts and sweatshirts for us. Not covered in flowers. Not wrapped in hearts. Not pretending the Emergency Department is a soft, quiet place. These are shirts for ER nurses, trauma junkies, night shifters, fast-track warriors, and yes—Murses. This episode marks the official launch of our apparel line built from the same culture this podcast lives in: controlled chaos, dark humor, competence under pressure, and the unspoken bond that forms when you’ve held the line at 0300 with no chair, no breaks, and no margin for error. These aren’t novelty shirts you wear once and forget. They’re conversation-starter shirts. The kind that get a nod from another nurse in the elevator. The kind that make an attending smirk. The kind a medic reads and says, “Yeah… that tracks.” Some designs are clean and professional—shirts you can wear under a jacket, to class, or into the hospital without looking like a walking meme. Others lean into the humor of ER life: the rapid pace, the gallows laughs, the “kept them alive till shift change” energy that only people in emergency medicine truly understand. This drop is about reclaiming ER nursing culture. About wearing something that actually reflects what we do. About finally having gear that doesn’t pretend we’re delicate—but still respects the professionalism of the job. And just as important: every shirt supports the podcast. This show exists to teach, educate, and talk honestly about emergency medicine—from real clinical lessons to the stuff nobody puts in textbooks. If you’ve learned something here, laughed here, or felt seen here, this is one way to keep it going. So whether you’re a new grad trying to find your footing, a seasoned trauma nurse who’s seen everything, or a Murse who’s tired of shopping the “women’s tee” section—this one’s for you. Grab your stuff. Report’s been given. We’ve got work to do. Shirts and sweatshirts are live now. And go checkout DudeRNCreations on Etsy to shop his products mentioned in the episode like the SYRINGE SOCKET

PEDI | Infection + SEPSIS

2026/02/04

Critical Bacterial & Toxin-Mediated Infections The most clinically significant bacterial infections require immediate recognition of airway compromise and strict adherence to antibiotic regimens. • Airway & Neurological Risks: ◦ Diphtheria: Caused by Corynebacterium diphtheriae, this presents with a "bull’s neck" (edema) and a pseudomembrane over the pharynx that can cause airway obstruction. Treatment involves antitoxins and antibiotics. ◦ Pertussis (Whooping Cough): Characterized by paroxysmal coughing and copious secretions, requiring careful airway management. ◦ Tetanus: Manifests as jaw cramping (lockjaw) and spasms. Prevention via immunization and wound cleaning is paramount; boosters may be required for injuries if more than 5 years have passed since the last dose. ◦ Botulism: A toxin-mediated infection causing generalized weakness, poor feeding, and a weak cry in infants, treated with Botulinum immune globulin. • Systemic & Soft Tissue Infections: ◦ Osteomyelitis: A bacterial bone infection (commonly S. aureus) presenting with fever, irritability, and tenderness. Management requires a long-term course (4–6 weeks) of antibiotics. ◦ Scarlet Fever: Resulting from Group A Strep, symptoms include high fever and a rash on the face and trunk. Droplet precautions are necessary. Vector-Borne & Parasitic Conditions Nurses must distinguish between self-limiting conditions and those requiring targeted medication to prevent complications. • Tick-Borne Diseases: ◦ Lyme Disease: Identified by a ring-like rash and joint pain. Without antibiotics (Doxycycline for children >8 years; Amoxicillin for 8 years), it can lead to neurological complications like cranial nerve palsy. ◦ Rocky Mountain Spotted Fever: Causes fever and rash; treated with Tetracycline. • Common Infestations: ◦ Pediculosis Capitis (Lice) & Scabies: Both cause intense pruritus (itching). Lice are treated with manual nit removal and permethrin, while scabies (mite lesions between digits) requires a scabicide left on for 8–14 hours. ◦ Pinworm: Characterized by anal itching and restlessness; diagnosed via a "tape test" and treated with anti-parasitics like mebendazole. Core Nursing Interventions (The Vital Few) The effectiveness of medical treatment relies heavily on supportive nursing care focused on prevention, comfort, and education. • Infection Control: Prevention is the first line of defense, including hand washing, adequate immunization, and proper food handling. • Symptom Management: ◦ Fever & Pain: Administer analgesics, encourage fluids, and dress febrile children in light clothing. Cool mist humidification aids respiratory comfort. ◦ Skin Integrity: Monitor rashes for infection. To prevent damage from scratching, keep fingernails short and apply antipruritics or cool compresses. • Patient Education: Teaching should be conducted in short sessions using multiple learning modes (visual, auditory). Nurses must assess the family's willingness to learn and provide reinforcement

PEDI | Cards

2026/02/04

Pediatric Cardiovascular Health Fetal to Pediatric Transition The cardiovascular system begins developing by postconceptual day 17. Fetal circulation relies on shunts—the foramen ovale (atria connection) and ductus arteriosus (pulmonary artery to aorta connection)—to bypass the lungs, as oxygenation occurs via the placenta. Post-birth, these shunts close. Pediatric vitals differ significantly from adults: infants have higher heart rates (90–160 bpm) and lower blood pressure, both of which normalize toward adult levels by adolescence. Congenital Heart Disease (CHD) CHD constitutes the largest percentage of birth defects. Defects are categorized by their effect on blood flow: • Increased Pulmonary Flow: Includes Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), and Patent Ductus Arteriosus (PDA). These involve holes or connections that allow blood to flood the lungs. • Obstructive Disorders: Involve narrowing of vessels, such as Coarctation of the Aorta or valve stenosis, restricting blood flow. • Decreased Pulmonary Flow: The classic example is Tetralogy of Fallot, characterized by four defects (including VSD and overriding aorta) causing cyanosis. • Mixed Defects: Complex issues like Transposition of the Great Arteries, where the pulmonary artery and aorta are swapped. Acquired Heart Disease Heart failure is the most common reason for admission in acquired cases. Key conditions include: • Kawasaki Disease: An acute systemic vascular inflammation (leading cause of acquired heart disease) requiring IV immunoglobulin and aspirin. • Infective Endocarditis: Bacterial infection of heart valves, often requiring long-term antibiotics. • Rheumatic Fever: An autoimmune reaction to Group A strep pharyngeal infections, occurring 2–4 weeks post-infection. Core Nursing Management Care focuses on four pillars: improving oxygenation, promoting adequate nutrition (critical due to high metabolic demand), preventing infection, and supporting family coping

PEDI | Rubella

2026/02/04

Rubella (German Measles) and Congenital Rubella Syndrome Rubella is a viral illness generally characterized by mild symptoms in children and adults but possessing devastating potential for developing fetuses. While endemic rubella was eliminated in the United States in 2004, maintaining high vaccination coverage remains critical to prevent reintroduction and protect pregnant women. The Critical Risk: Congenital Rubella Syndrome (CRS) The primary objective of rubella management is preventing Congenital Rubella Syndrome (CRS). • Impact on Pregnancy: Infection during early pregnancy, especially the first 12 weeks, can lead to miscarriage, stillbirth, or severe birth defects. • Severe Defects: CRS causes a constellation of permanent disabilities, including deafness, cataracts, congenital heart disease, intellectual disability, and liver damage. • Viral Shedding: Unlike typical cases, infants born with CRS may shed the virus in bodily fluids for up to one year, making them highly contagious to unvaccinated contacts. Clinical Presentation Rubella is often mild and up to 50% of infections are subclinical (symptom-free), yet these individuals can still transmit the virus. • Symptoms: The hallmark sign is a maculopapular rash that starts on the face and spreads downward, lasting about 3 days. Other symptoms include low-grade fever, swollen lymph nodes (lymphadenopathy), and mild pink eye. • Adult Complications: While children recover quickly, up to 70% of infected women experience arthritis or joint pain (arthralgia), which can last up to a month. • Transmission: The virus spreads via respiratory droplets. Individuals are contagious from 7 days before to 7 days after the rash appears. Prevention and Vaccination The most effective defense against rubella is the live, attenuated vaccine, available as MMR (Measles, Mumps, Rubella) or MMRV (including Varicella). • Efficacy: A single dose produces immunity in at least 95% of people, conferring long-term protection. • Schedule: The standard schedule requires two doses: the first at 12–15 months and the second at 4–6 years. • Safety: The vaccine is safe; common side effects are mild fever or rash. Serious adverse events like febrile seizures are rare, and studies refute any link between the vaccine and autism. Contraindications and Precautions Because the vaccine contains a live virus, specific restrictions apply: • Pregnancy: Vaccination is contraindicated during pregnancy due to theoretical risks to the fetus. Women should avoid becoming pregnant for 4 weeks after vaccination. However, accidental vaccination during pregnancy has not been shown to cause CRS in offspring. • Immunocompromise: Persons with severe immunodeficiency or those on high-dose steroids should not receive the vaccine. • Illness: Vaccination should be deferred for those with moderate or severe acute illness

PEDI | Pertussis

2026/02/04

Pertussis (Whooping Cough) is a highly contagious, acute respiratory disease caused by the bacterium Bordetella pertussis. It is primarily a toxin-mediated disease where bacteria attach to respiratory cilia, paralyzing them and causing inflammation that hinders the clearing of secretions. While it affects all ages, it is most dangerous for infants, potentially leading to apnea (pauses in breathing), pneumonia, and death. The Three Clinical Stages The hallmark of Pertussis is its progression through three distinct stages over several weeks or months: • 1. Catarrhal Stage (1–2 weeks): This is the most infectious phase. Symptoms resemble a common cold—runny nose, low-grade fever, and mild cough. Because symptoms are nonspecific, diagnosis is often missed here, facilitating spread. • 2. Paroxysmal Stage (1–6+ weeks): The cough becomes severe, occurring in rapid bursts (paroxysms) due to thick mucus. ◦ The "Whoop": A long inspiratory effort following a coughing fit often creates a high-pitched "whoop". ◦ Post-tussive Vomiting: Vomiting and exhaustion frequently follow coughing spells. ◦ Infant Presentation: Infants 6 months often lack the strength to "whoop." Instead, they may present with apnea (cessation of breathing), cyanosis, or gagging. • 3. Convalescent Stage (Weeks to months): Recovery is gradual. Coughing lessens but paroxysms can recur with subsequent respiratory infections. Transmission and Epidemiology • Highly Contagious: Transmission occurs via respiratory droplets. Secondary attack rates in households can reach 80%. • Reservoirs: Humans are the only reservoir. Adults and adolescents with milder disease (often asymptomatic or just a persistent cough) are frequently the source of infection for infants. • Resurgence: despite vaccination, cases have increased in the U.S. since the 1980s. This is attributed to better reporting, diagnostic changes, and waning immunity from newer acellular vaccines. Diagnosis and Treatment • Diagnosis: Polymerase Chain Reaction (PCR) is the preferred rapid test, most sensitive in the first 3 weeks of cough. Culture is the gold standard but difficult to perform. • Antibiotics: Macrolides (azithromycin, clarithromycin) are the treatment of choice. ◦ Timing is Key: Antibiotics eradicate the bacteria and stop transmission. They only modify the course of illness if started early (catarrhal stage). If started during the paroxysmal stage, they prevent spread to others but do not reduce symptoms. • Management: Treatment is largely supportive (hydration, oxygen). Hospitalization is often required for young infants for monitoring of apnea. Prevention and Vaccination Vaccination is the primary preventive strategy, though immunity is not permanent. • DTaP: Administered to children under 7 years (2, 4, 6, 15-18 months, and 4-6 years). • Tdap: A booster for adolescents (11-12 years) and adults. Pregnant women should receive Tdap during every pregnancy to pass antibodies to the fetus. • Post-Exposure: All close contacts of a case should receive antibiotics regardless of vaccination status to prevent transmission

PEDI | Varicella (Chickenpox)

2026/02/04

Varicella (chickenpox) is an acute infectious disease caused by the varicella-zoster virus (VZV), a DNA virus in the herpesvirus group,. Following primary infection, the virus persists as a latent infection in sensory nerve ganglia and can reactivate later in life as herpes zoster (shingles),. • Transmission: The virus is highly contagious and spreads person-to-person via air (coughing/sneezing) or direct contact with vesicular fluid. It is communicable from 1–2 days before the rash appears until all lesions have crusted,. • Incubation: Symptoms typically develop 10 to 21 days after exposure,. • Symptoms: The hallmark symptom is an itchy rash that progresses rapidly from flat red spots (macules) to fluid-filled blisters (vesicles) and finally to scabs,. Lesions appear in successive "crops," meaning different stages of the rash are present simultaneously. Clinical Severity and Complications While often mild in healthy children, varicella can be severe or life-threatening in adults, pregnant women, and immunocompromised individuals,. • Complications: Common complications include secondary bacterial skin infections (Staphylococcus or Streptococcus) and pneumonia. Central nervous system issues, such as encephalitis and cerebellar ataxia, are rare but serious. • Reye Syndrome: Aspirin or salicylate-containing products must never be given to children with chickenpox, as this significantly increases the risk of Reye syndrome, a serious condition affecting the liver and brain,. • Pregnancy: Maternal infection in the first 20 weeks of gestation can result in congenital varicella syndrome (limb hypoplasia, scarring, microcephaly). Vaccination and Immunity Since the introduction of the vaccine in 1995, varicella incidence in the U.S. has declined by an average of 97%. • Vaccine Types: Two live, attenuated vaccines are licensed: VAR (Varivax) and the combination MMRV (ProQuad). • Schedule: A 2-dose series is recommended for children: the first dose at 12–15 months and the second at 4–6 years. Adolescents and adults without immunity should also receive two doses, spaced at least 4 weeks apart. • Efficacy: Two doses are 92% effective against any clinical varicella and 98% effective against severe disease. • Breakthrough Infection: Infection can occur in vaccinated individuals but is typically milder, often with fewer than 50 lesions and no fever. • Contraindications: Live vaccines should not be administered to pregnant women, individuals with severe allergic reactions to vaccine components (gelatin/neomycin), or those with severe immunosuppression (e.g., certain HIV counts, leukemia),. Post-Exposure and Management • Prophylaxis: Vaccination is 70% to 100% effective in preventing or modifying illness if administered within 3 to 5 days of exposure. • Treatment: Routine care involves fluids, acetaminophen for fever, and anti-itch lotions. Antiviral medicines are reserved for those at high risk of complications, such as adults and immunocompromised patients

PEDI | Tetanus

2026/02/04

Tetanus is an acute, potentially fatal disease caused by the neurotoxin of the bacterium Clostridium tetani. While the spores are ubiquitous in the environment, the disease is entirely preventable through vaccination. Pathology and Clinical Presentation • Mechanism: C. tetani spores, found in soil and animal manure, enter the body through wounds. In anaerobic conditions (lack of oxygen), spores germinate and produce tetanospasmin, a potent neurotoxin. • Neurotoxicity: The toxin disseminates via blood and lymphatics to the central nervous system, where it blocks inhibitory neurotransmitters. This results in unopposed muscle contraction and severe spasms. • Symptoms: The incubation period averages 8 days (range 1–21 days). ◦ Trismus (Lockjaw): The most common early sign, followed by neck stiffness and difficulty swallowing. ◦ Generalized Rigidity: Abdominal stiffness and painful spasms that can fracture bones or cause respiratory failure (laryngospasm). ◦ Fatality: Approximately 11% of cases are fatal, often due to respiratory or cardiac complications. Vaccination Protocols (Prevention) Immunization is the primary defense, as recovering from the disease does not confer immunity. • Children (DTaP): The CDC recommends a 5-dose series of Diphtheria, Tetanus, and acellular Pertussis vaccine at ages 2, 4, 6 months, 15–18 months, and 4–6 years. • Adolescents & Adults (Tdap/Td): ◦ Adolescents receive a Tdap booster at age 11–12. ◦ Adults should receive a booster (Td or Tdap) every 10 years. • Pregnancy: Women should receive a Tdap dose during every pregnancy (weeks 27–36) to pass immunity to the infant and prevent neonatal tetanus. Clinical Management and Wound Prophylaxis Diagnosis is clinical; there are no effective laboratory tests. Treatment focuses on neutralizing the toxin and supportive care. • Immediate Treatment: Airway maintenance, sedation for spasms, and thorough wound cleaning. • Tetanus Immune Globulin (TIG): Recommended for active cases to remove unbound toxin. TIG provides temporary immediate immunity. • Antibiotics: Secondary to wound cleaning and immunization; prophylaxis alone is not useful. The "Dirty Wound" Decision Matrix Clinicians must decide between giving a vaccine booster, TIG, or both, based on the wound type and vaccination history: Vaccination History Clean, Minor Wound Action All Other Wounds (Dirt, Feces, Puncture) Unknown or 10 years since last dose No action unless >5 years since last dose Key Takeaway: For dirty or complex wounds, the threshold for a booster drops from 10 years to 5 years, and those with incomplete vaccination history require immediate passive immunity via TIG

PEDI | Mumps

2026/02/04

Mumps is an acute, contagious viral illness characterized by the swelling of salivary glands (parotitis). Historically a leading cause of aseptic meningitis and hearing loss in children, widespread vaccination has reduced cases by over 99%, though outbreaks continue to occur in close-contact settings. Clinical Presentation and Transmission • Symptoms: The hallmark symptom is parotitis (swelling of the parotid glands at the jaw), which lasts about 5 days. Prodromal symptoms are nonspecific, including low-grade fever, headache, myalgia (muscle pain), anorexia, and malaise. Approximately 15–24% of infections are asymptomatic. • Transmission: The virus spreads via respiratory droplets and saliva. • Contagiousness: Patients are infectious from 2 days before to 5 days after the onset of parotitis. It is considered as contagious as influenza but less so than measles. • Incubation: Symptoms typically appear 16 to 18 days after exposure. Complications While usually mild in children, mumps can cause serious complications, which are more common in adults and unvaccinated individuals. • Orchitis: The most common complication in post-pubertal males (inflammation of the testicles), occurring in up to 30% of unvaccinated men. It involves abrupt onset of pain and swelling and can lead to testicular atrophy. • Other Inflammations: Oophoritis (ovaries), mastitis (breasts), and pancreatitis. • Neurological: Meningitis and encephalitis occur but are rare (≤1%) in the post-vaccine era. • Hearing Loss: Sensorineural hearing loss can occur and may be permanent. Vaccination and Prevention Vaccination is the primary preventive measure. The U.S. uses the MMR (measles, mumps, rubella) or MMRV (includes varicella) vaccines, which contain live, attenuated virus. • Efficacy: One dose is approximately 78% effective; two doses are 88% effective. • Standard Schedule: ◦ Dose 1: Age 12–15 months. ◦ Dose 2: Age 4–6 years. • Contraindications: Pregnancy and severe immunocompromise are major contraindications. • Safety: The vaccine is safe. Fever and rash may occur. There is no causal link between the vaccine and autism. • Outbreaks: Since 2006, cases have risen, often in close-contact environments like colleges. During outbreaks, public health authorities may recommend a third dose of MMR for high-risk groups. Diagnosis and Management • Diagnosis: Clinical suspicion (parotitis) should be confirmed via RT-PCR (buccal or urine swab). Serology (IgM) is less reliable due to false negatives in vaccinated individuals. • Treatment: There is no specific antiviral treatment. Management is supportive care involving fluids, bed rest, and analgesics (acetaminophen or ibuprofen). Aspirin must be avoided in children due to the risk of Reye syndrome

PEDI | Measles (rubeola)

2026/02/04

Measles (rubeola) is an acute, highly contagious viral respiratory illness characterized by a distinct prodrome of fever and the "three Cs" (cough, coryza, and conjunctivitis), followed by a generalized rash. While indigenous transmission was declared eliminated in the U.S. in 2000, outbreaks continue to occur due to importation and unvaccinated populations. Clinical Presentation and Transmission • High Infectivity: The virus spreads via respiratory droplets and can remain airborne in closed areas for up to 2 hours. It is highly communicable, with a secondary attack rate of over 90% among susceptible contacts. • Contagious Period: Patients are contagious from 4 days before until 4 days after the rash appears. • Symptom Timeline: ◦ Incubation: Symptoms typically begin 7 to 14 days after exposure. ◦ Prodrome: Characterized by a stepwise fever rising to 103°F–105°F, cough, runny nose, and pink eye. ◦ Koplik Spots: Small blue-white spots on the inner cheek appear 1–2 days before the rash; these are considered unique to measles. ◦ Rash: A deep red, maculopapular rash begins at the hairline and spreads downward to the neck, torso, and extremities over 3 days. • Complications: Common complications include ear infections and diarrhea, while severe outcomes include pneumonia, encephalitis (brain inflammation), and death. Vaccination Protocols (MMR and MMRV) Prevention relies on the live, attenuated MMR (measles, mumps, rubella) or MMRV (+ varicella) vaccines. • Standard Schedule: Two doses are recommended for children: 1. Dose 1: Age 12 through 15 months. 2. Dose 2: Age 4 through 6 years (before school entry). • Efficacy: A single dose produces immunity in ~95% of children, while two doses provide >99% immunity, which is expected to be lifelong. • MMRV Precautions: For the first dose in children aged 12–47 months, administering separate MMR and Varicella vaccines is preferred over the combined MMRV shot, as MMRV carries a twofold higher risk of febrile seizures in this specific age group. • Adults and Travelers: Adults without evidence of immunity and international travelers (including infants 6–11 months) require vaccination, as measles remains endemic globally. Safety and Contraindications • Contraindications: Because it is a live vaccine, it must not be administered to pregnant women or individuals with severe immunocompromise (e.g., untreated HIV, leukemia, or high-dose steroid therapy). • Adverse Events: Common side effects include fever (5–15%) and a transient rash (5%) occurring 7–12 days post-vaccination. • Autism: Extensive studies and reviews by the National Academy of Medicine have refuted a causal relationship between the MMR vaccine and autism

PEDI | Infection

2026/02/04

PEDI | Cards Pharmacology

2026/02/04

Part 1: Pediatric Cardiovascular Health Fetal to Pediatric Transition The cardiovascular system begins developing by postconceptual day 17. Fetal circulation relies on shunts—the foramen ovale (atria connection) and ductus arteriosus (pulmonary artery to aorta connection)—to bypass the lungs, as oxygenation occurs via the placenta. Post-birth, these shunts close. Pediatric vitals differ significantly from adults: infants have higher heart rates (90–160 bpm) and lower blood pressure, both of which normalize toward adult levels by adolescence. Congenital Heart Disease (CHD) CHD constitutes the largest percentage of birth defects. Defects are categorized by their effect on blood flow: • Increased Pulmonary Flow: Includes Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), and Patent Ductus Arteriosus (PDA). These involve holes or connections that allow blood to flood the lungs. • Obstructive Disorders: Involve narrowing of vessels, such as Coarctation of the Aorta or valve stenosis, restricting blood flow. • Decreased Pulmonary Flow: The classic example is Tetralogy of Fallot, characterized by four defects (including VSD and overriding aorta) causing cyanosis. • Mixed Defects: Complex issues like Transposition of the Great Arteries, where the pulmonary artery and aorta are swapped. Acquired Heart Disease Heart failure is the most common reason for admission in acquired cases. Key conditions include: • Kawasaki Disease: An acute systemic vascular inflammation (leading cause of acquired heart disease) requiring IV immunoglobulin and aspirin. • Infective Endocarditis: Bacterial infection of heart valves, often requiring long-term antibiotics. • Rheumatic Fever: An autoimmune reaction to Group A strep pharyngeal infections, occurring 2–4 weeks post-infection. Core Nursing Management Care focuses on four pillars: improving oxygenation, promoting adequate nutrition (critical due to high metabolic demand), preventing infection, and supporting family coping. -------------------------------------------------------------------------------- Part 2: Pharmacology Spotlight — Propranolol Drug Class and Mechanism Propranolol is a non-selective beta-blocker (Class II anti-arrhythmic). It works by competing with catecholamines at receptor sites. It blocks beta-1 receptors (heart) to lower heart rate and blood pressure, and beta-2 receptors (lungs/vascular), which can inadvertently cause bronchospasm. Indications It is a versatile drug used for: • Cardiac: Hypertension, angina, and arrhythmias. • Non-Cardiac: Migraine prophylaxis, essential tremor, anxiety, and infantile hemangioma. Critical Safety Warnings • Boxed Warning: Do not abruptly discontinue. Stopping suddenly can exacerbate angina or precipitate myocardial infarction. Dosage must be tapered over at least 2 weeks. • Side Effects: Bradycardia, hypotension, bronchospasm (caution in asthmatics), and masking of hypoglycemia symptoms. Administration Guidelines • Oral: Immediate-release tablets should be taken with food. • Infantile Hemangioma (Hemangeol): Administer during or right after feeding to prevent hypoglycemia. Do not shake the bottle. Doses are given via oral syringe against the cheek.

PEDI | Cards C/ NO DRUGS

2026/02/04

PEDI | Cards C/ Drugs

2026/02/04

PEDI | Respiratory

2026/01/29

The pediatric respiratory system differs significantly from adults, making children prone to rapid decompensation. • Airway Size: An infant's trachea is approximately 4 mm wide (vs. 20 mm in adults). Even 1 mm of edema can reduce the airway diameter by 50%, significantly increasing resistance and work of breathing. • Physiology: Children have higher metabolic rates and oxygen consumption (6–8 L/min vs. 3–4 L/min in adults), causing hypoxemia to develop more rapidly during distress. • Assessment Priorities: The first sign of respiratory illness is often tachypnea. Other critical signs include retractions (suprasternal, intercostal), nasal flaring, grunting, and head bobbing. Quiet chests in asthmatics can indicate severe obstruction (lack of air movement) rather than improvement. Croup (Laryngotracheobronchitis) Barking/seal-like cough, inspiratory stridor, low-grade fever. Cool mist humidity, corticosteroids (dexamethasone), nebulized racemic epinephrine. Monitor for rebound bronchospasm after racemic epinephrine wears off. Epiglottitis Medical Emergency. Drooling, agitation, tripod positioning, frog-like croaking, high fever. Protect the airway immediately. Prepare for intubation. IV antibiotics and humidified oxygen. NEVER visualize the throat (tongue blade) or obtain a culture; this may trigger complete airway occlusion. Bronchiolitis (often RSV) Copious thick secretions, wheezing, tachypnea, poor feeding. Suctioning (especially before feeds), hydration, and supplemental oxygen if sat 90%. Bronchodilators and corticosteroids are generally not recommended. Use contact precautions. Chronic Management Priorities 1. Asthma Asthma is characterized by inflammation, bronchoconstriction, and mucus. Management is tiered: • Rescue: Short-acting beta2-agonists (SABA) like albuterol are used for acute exacerbations to relax airway smooth muscle. • Maintenance: Inhaled corticosteroids (e.g., fluticasone) and leukotriene modifiers (e.g., montelukast) suppress inflammation and prevent attacks. • Monitoring: Use a peak flow meter to establish a "personal best." A reading in the Red Zone (50%) requires immediate bronchodilators and medical attention. 2. Cystic Fibrosis (CF) An autosomal recessive disorder causing thick, tenacious mucus that blocks alveoli and pancreatic ducts. • Respiratory Care: Airway clearance is mandatory. Techniques include Chest Physiotherapy (CPT) and high-frequency chest oscillation vests, often preceded by bronchodilators or dornase alfa (to thin mucus). • Nutritional Care: Patients require pancreatic enzymes with all meals and snacks to digest food. The diet must be high-calorie and high-protein, with fat-soluble vitamin supplementation (A, D, E, K). Critical Nursing Safety Alerts • Tonsillectomy: The most common complication is hemorrhage. Monitor for frequent swallowing (a sign of trickling blood), tachycardia, and bright red emesis. Discourage coughing or clearing the throat. • Foreign Body Aspiration: Most common in ages 6 months to 3 years. Avoid latex balloons, peanuts, and popcorn. If obstruction occurs, use back blows/chest thrusts (infant) or abdominal thrusts (older child). • Oxygen Therapy: Oxygen is a drug. In chronic hypercapnia (like CF), indiscriminate oxygen use can suppress the respiratory drive. Use the lowest liter flow to correct hypoxemia.

PEDI | Sensory (Eyes & Ears)

2026/01/29

• Visual Development: Binocular vision (using both eyes together) is not fully achieved until age 5. Disorders like strabismus (misalignment) must be corrected early to prevent amblyopia (lazy eye), which can cause permanent vision loss if the brain "turns off" the weaker eye. High-Yield Eye Disorders 1. Conjunctivitis ("Pink Eye") Differentiation is key for treatment: • Bacterial: Purulent (pus-like) discharge, mild pain, often unilateral. Tx: Antibiotic drops/ointment. • Viral: Watery discharge, lymphadenopathy, tearing. Tx: Symptom relief only. • Allergic: Itching is the hallmark symptom, watery/stringy discharge. Tx: Antihistamines. • Nursing Priority: Infection control. Viral/bacterial forms are highly contagious. Isolate for 24 hours after starting antibiotics; discourage towel sharing. 2. Structural & Functional Issues • Strabismus (Cross-eye): Normal in young infants but pathological if persistent. Treatment is critical to preserve vision. • Amblyopia: The brain suppresses the image from the "bad" eye. Intervention: Patch the healthy eye for several hours daily to force the weaker eye to work. • Retinopathy of Prematurity (ROP): Rapid growth of retinal blood vessels in preemies. Risk Factors: Low birth weight, early gestation, sepsis, and high/prolonged oxygen therapy. 3. Trauma • Corneal Abrasions: Painful scratches. Do not patch the eye (increases infection risk). • Hyphema/Black Eye: Apply ice packs for 20 minutes on/off. • Emergency: Fixed/dilated pupils or objects penetrating the globe require immediate referral to ophthalmology. High-Yield Ear Disorders 1. Acute Otitis Media (AOM) • Signs: Rapid onset, ear pain (otalgia), bulging/red tympanic membrane, fever, pulling at ears. • Management: "Watchful waiting" for 48-72 hours is common for older children to avoid overuse of antibiotics. If bacterial, antibiotics are prescribed. Pain management (analgesics) is a priority. 2. Otitis Media with Effusion (OME) • Signs: Fluid in the middle ear without acute infection signs. The membrane looks dull, opaque, or gray with visible fluid levels. • Risk: Can persist for months, causing conductive hearing loss and speech delay. • Intervention: Pressure-equalizing (PE) tubes are surgically inserted for chronic cases to drain fluid. 3. Otitis Externa ("Swimmer's Ear") • Signs: Infection of the ear canal. Hallmark sign is significant pain when pressure is applied to the tragus. • Tx: Antibiotic/antifungal ear drops. Wick insertion may be needed if swelling is severe. Key Nursing Interventions & Assessments • Assessment Cues: ◦ Vision: Infants should "fix and follow" objects. A dull, vacant stare or lack of eye contact is a red flag for visual impairment. ◦ Hearing: Lack of startle reflex to loud noises or failure to babble by 6 months indicates potential hearing loss. • Post-Op Care: ◦ Eye Surgery (Cataracts/Strabismus): Use elbow restraints to prevent the child from rubbing the operative site. Protect the site with patching.